Pharmacological treatment of posttraumatic stress disorder;Tratamento farmacológico do transtorno de estresse pós-traumático

Revista Brasileira de Psiquiatria

Volumn 25, Issue SUPPL. 1, 2003, Pages 46-50

  Bernik, Márcio ^a,b   Laranjeiras, Marcionilo ^a   Corregiari, Fábio ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Ambulatorio de Ansiedade do Ipq HC   (Brazil)

^c NONE

Author keywords

Anticonvulsants; Antidepressants; Lithium; Pharmacological treatment; Posttraumatic stress disorder

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

BRAZIL; DRUG EFFECT; DRUG EFFICACY; HUMAN; POSTTRAUMATIC STRESS DISORDER; REVIEW; SEROTONINERGIC SYSTEM;

EID: 0038711751     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462003000500011     Document Type: Review

References (43)

1. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and post-traumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychitry 1998;55:626-32.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4rd ed. Washington (DC): American Psychiatric Association; 1994.
3. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993;50:294-302.
4. Davidson JRT. Biological therapies for posttraumatic stress disorder: an overview. J Clin Psychiatry 1997;58(Suppl 9):29-32.
5. Davidson JR, Kudler HS, Saunders WB, Erickson L, Smith RD, Stein RM et al. Predicting response to amitriptyline in posttraumatic stress disorder. Am J Psychiatry 1993;150:1024-9.
6. Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL Jr. Pharmacotherapy for posttraumatic stress disorder using phenelzine of imipramine. J Nerv Ment Dis 1991;179:336-70.
7. Reist C, Kauffmann CD, Haier RJ, Sangdahl C, DeMet EM, Chicz-DeMet A, Nelson JN. A controlled study of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 1989;146:513-6.
8. Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990;47:259-66.
9. Dow B, Kline N. Antidepressant treatment of posttraumatic stress disorder and major depression in veterans. Ann Clin Psychiatry 1997;9:1-5.
10. Nagy LM, Morgan CA 3rd, Southwick SM, Charney DS. Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol 1993;13:107-13.
11. Nagy LM, Southwick SM, Charney DS. Placebo-controlled trial of fluoxetine in PTSD. Poster presented at the annual meeting of the International Society for Traumatic Stress Studies, San Francisco, CA, November; 1996.
12. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:517-22.
13. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR. Fluoxetine in post-traumatic stress disorder. Br J Psychiatry 1999;175:17-22.
14. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 2000;12(2):101-5.
15. Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry 2002;63(3):199-206.
16. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM. Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA 2000;283:1837-44.
17. Davidson JR, Landerman LR, Farfel GM, Clary CM. Characterizing the effects of sertraline in post-traumatic stress disorder. Psychol Med 2002;32(4):661-70.
18. Rapaport MH, Endicott J, Clary CM. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry 2002;63(1):59-65.
19. Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, Austin C. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol 2002;22(2):190-5.
20. Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA, Goetz D et al. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychiatry 1998;18:10-8.
21. Marmar CR, Schoenfeld F, Weiss DS, Metzler T, Zatzick D, Wu R et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 1996;57(suppl 8):66-72.
22. Davidson JR, Weisler RH, Malik M, Tupler LA. Fluvoxamine in civilians with posttraumatic stress disorder (letter). J Clin Psychopharmacol 1998;18:93-5.
23. De Boer M, Op den Velde W, Falger PJ, Hovens JE, De Groen JH, Van Duijn H. Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom 1992;57:158-63.
24. Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JR. Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder. Ann Clin Psychiatry 2002;14(4):215-21.
25. Lerer B, Bleich A, Kotler M, Garb R, Hertzberg M, Levin B. Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment. Arch Gen Psychiatry 1987;44:976-81.
26. Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. J Psychiatr Res 1988;24:149-55.
27. th Annual Meeting, Los Angeles, CA, May 1985. Washington (DC): American Psychiatric Association; 1985.
28. Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390-4.
29. Lowenstein RJ, Hornstein N, Farber B. Open trial of clonazepam in the treatment of posttraumatic stress symptoms of multiple personality disorder. Dissociation 1988;1:3-12.
30. Braun P, Greenberg D, Dasberg H, Lerer B. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 1990;51:236-8.
31. Duffy JD, Malloy PF. Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial. Ann Clin Psychiatry 1994;6:33-7.
32. Fichtner CG, Crayton JW. Buspirone in combat-related posttraumatic stress disorder (letter). J Clin Psychopharmacol 1994;14:79-81.
33. Forster PL, Schoenfeld FB, Marmar CR, Lang AJ. Lithium for irritability in posttraumatic stress disorder. J Trauma Stress 1995;8:143-9.
34. Kitchner I, Greenstein R: Low dose lithium carbonate in the treatment of post-traumatic stress disorder. Mil Med 1985;150:378-81.
35. Lipper S, Davidson JR, Grady TA, Edinger JD, Hammett EB, Mahorney SL, Cavenar JO Jr. Preliminary study of carbamazepine in post-traumatic stress disorder. Psychosomatics 1986;27:849-54.
36. Wolf ME, Alavi A, Mosnaim AD. Posttraumatic stress disorder in Vietnam veterans: clinical and EEG findings; possible therapeutic effects of cabamazepine. Biol Psychiatry 1988;23:642-4.
37. Fesler FA. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry 1991;52:361-4.
38. Hertzberg MA, Butterfield MI, Feldman ME, Beckham JC, Sutherland SM, Connor KM, Davidson JR. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999;45:1226-9.
39. Hamner MB, Deitsch SE, Brodrick PS, Ulmer HG, Lorberbaum JP. Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol 2003;23(1):15-20.
40. Hamner MB, Faldowski RA, Ulmer HG, Frueh BC, Huber MG, Arana GW. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol 2003;18(1):1-8.
41. Butterfield MI, Becker ME. Connor KM, Sutherland S, Churchill LE, Davidson JR. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol 2001;16:1-7.
42. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-60.
43. Breslau N, Davis GC, Andreski P, Peterson EL, Schultz LR. Sex differences in posttraumatic stress disorder. Arch Gen Psychiatry 1997;54:1044-8.